LAIYANG, China, Jan. 15, 2008 (PRIME NEWSWIRE) -- Genesis Pharmaceuticals Enterprises, Inc. (OTCBB:GTEC) ("Genesis" or the "Company"), a leading pharmaceutical company in the People's Republic of China, today announced that the Company filed an annual report on Form 10-KSB with the Securities and Exchange Commission ("SEC"), for the fiscal year ended September 30, 2007. The 10-KSB discloses the financial results of the Company's antecedent business of advising small to mid-sized Chinese companies regarding U.S. capital markets.
